A human neuronal model of Niemann Pick C disease developed from stem cells isolated from patient's skin

• Published in: Orphanet journal of rare diseases Vol. 8; no. 1; p. 34
• Main Authors: Bergamin, Natascha, Dardis, Andrea, Beltrami, Antonio, Cesselli, Daniela, Rigo, Silvia, Zampieri, Stefania, Domenis, Rossana, Bembi, Bruno, Beltrami, Carlo Alberto
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 21.02.2013; BioMed Central
• Subjects: Animals; Biopsy; Care and treatment; Cell Differentiation; Cell Engineering - methods; Cells, Cultured; Cholesterol - metabolism; Coculture Techniques; Diagnosis; Fibroblasts - cytology; Gangliosides - metabolism; Genetic aspects; Health aspects; Humans; Lipids; Medical equipment and supplies industry; Medical research; Medical test kit industry; Mutation; Nervous system diseases; Neurons - cytology; Neurons - metabolism; Neurons - pathology; Niemann-Pick disease; Niemann-Pick Disease, Type C - pathology; Proteins; Rare diseases; Risk factors; Skin - cytology; Stem cell research; Stem cells; Stem Cells - cytology; United States
• ISSN: 1750-1172; 1750-1172
• DOI: 10.1186/1750-1172-8-34

Niemann Pick C (NPC) disease is a neurovisceral lysosomal storage disorder due to mutations in NPC1 or NPC2 genes, characterized by the accumulation of endocytosed unesterified cholesterol, gangliosides and other lipids within the lysosomes/late endosomes. Even if the neurodegeneration is the main feature of the disease, the analysis of the molecular pathways linking the lipid accumulation and cellular damage in the brain has been challenging due to the limited availability of human neuronal models. The aim of this study was to develop a human neuronal model of NPC disease by inducing neuronal differentiation of multipotent adult stem cells (MASC) isolated from NPC patients. Stem cells were isolated from 3 NPC patients and 3 controls both from skin biopsies and previously established skin fibroblast cultures. Cells were induced to differentiate along a neuronal fate adapting methods previously described by Beltrami et al, 2007. The surface immunophenotype of stem cells was analyzed by FACS. Stem cell and neuronal markers expression were evaluated by immunofluorescence. Intracellular accumulation of cholesterol and gangliosides were assessed by filipin staining and immunofluorescence, respectively. A morphometric analysis was performed using a Neurite outgrowth image program. After 3 passages in selective medium, MASC isolated either from skin biopsies or previously established skin fibroblast cultures displayed an antigenic pattern characteristic of mesenchymal stem cells and expressed the stem cell markers Oct-4, Nanog, Sox-2 and nestin. A massive lysosomal accumulation of cholesterol was observed only in cells isolated from NPC patients. After the induction of neural differentiation, remarkable morphologic changes were observed and cells became positive to markers of the neuronal lineage NeuN and MAP2. Differentiated cells from NPC patients displayed characteristic features of NPC disease, they showed intracellular accumulation of unesterified cholesterol and GM2 ganglioside and presented morphological differences with respect to cells derived from healthy donors.In conclusion, we generated a human neuronal model of NPC disease through the induction of differentiation of stem cells obtained from patient's easily accessible sources. The strategy described here may be applied to easily generate human neuronal models of other neurodegenerative diseases.